CMH Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
CMH Wealth Management's NVS Position: Q3 2026 in Review
CMH Wealth Management reduced its Novartis (NVS) stake by 4.9% in Q3 2026, selling an estimated $84.2K and leaving 10,878 shares worth $1.55M. The position accounts for 0.23% of the portfolio, ranked #69.
CMH Wealth Management first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.79M in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- CMH Wealth Management held 10,878 shares of Novartis worth $1.55M as of Q3 2026.
- CMH Wealth Management sold 555 Novartis shares in Q3 2026, an estimated $84.2K.
- Novartis made up 0.23% of CMH Wealth Management's portfolio in Q3 2026, its #69 holding.
- CMH Wealth Management first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
- CMH Wealth Management's Novartis position peaked at $1.79M in Q2 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on CMH Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.